Upstream Processing Featured Articles

31. Thermo Fisher Scientific Introduces Data System To Unite Chromatography And Mass Spectrometry 3/18/2013

    Thermo Fisher Scientific Inc., the world leader in serving science, recently introduced the next generation of its gold-standard Chromeleon chromatography data system (CDS), which now supports mass spectrometry along with mainstream front-end separation techniques in the same software package.

32. Finesse Solutions Launches TruBio DV 4.5 Bioreactor Control Software For Its Novel SmartParts Component Platform 3/18/2013

    Finesse Solutions, Inc., Santa Clara, CA, a manufacturer of measurement and control solutions for life science process applications, announced the release of TruBio DV version 4.5 bioreactor control software that leverages its new SmartParts components.

33. New Monoclonal Antibody Developed That Can Target Proteins Inside Cancer Cells 3/13/2013

    Researchers have discovered a unique monoclonal antibody that can effectively reach inside a cancer cell, a key goal for these important anticancer agents, since most proteins that cause cancer or are associated with cancer are buried inside cancer cells.

34. Scientists Discover Why Some Proteins Are Speedier Than Others 3/11/2013

    Scientists at the University of Bath have solved a problem that has frustrated biologists for years – why different parts of proteins are made at different rates.

35. Pittcon 2013 Announces Exposition Highlights 3/5/2013

    The Pittcon 2013 Exposition, which takes place March 17-21, at the Pennsylvania Convention Center, Philadelphia, Pennsylvania, will include 1,011 exhibitors (count as of March 1, 2013) displaying products and services used by the scientific community in industrial, academic, and government labs.

36. Thallion And LFB Terminate Shigamabs Collaboration 2/20/2013

    Thallion Pharmaceuticals Inc. (TSX-V: TLN) ("Thallion") and LFB Biotechnologies ("LFB") today announced that they have reached an agreement on the termination of their Development and Licensing Agreement related to Thallion's Shigamabs® program.

37. MorphoSys And Heptares Sign Alliance To Develop Antibody Therapeutics Targeting GPCRs 2/13/2013

    MorphoSys AG (Prime Standard Segment, TecDAX) and UK-based Heptares Therapeutics, the leading GPCR drug discovery and development company, have signed an agreement to discover novel antibody therapeutics targeting G protein-coupled receptors (GPCRs), which are membrane proteins involved in a broad range of biological processes and diseases.

38. Virus Engineered To Express Melanin Offers New Possibilities To Diagnose And Treat Solid Tumor Cancers 2/11/2013

    In a study released today in Proceedings of the National Academy of Sciences (PNAS), entitled "Vaccinia virus mediated melanin production allows MR and optoacoustic deep tissue imaging and laser induced thermotherapy of cancer," scientists combined the natural imaging potential of melanin with recombinant Vaccinia viruses' ability to selectively enter and replicate within tumor cells.

39. MorphoSys Receives First Patent On Novel Antibody Platform Ylanthia In The US 2/8/2013

    MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX) today announced that the US Patent and Trademark Office (USPTO) has granted the first patent covering the Company's latest antibody platform Ylanthia, which became commercially available for existing and new partners in 2012.

40. Advion Announces Full Integration With Agilent Technologies Liquid Chromatography Systems 12/10/2012

    Advion, Inc., a leading life sciences Systems and Consumables developer, announces that its expression compact mass spectrometer (CMS) is now fully integrated with Agilent Technologies’ full range of HPLC and (U)HPLC liquid chromatography systems.